Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Even light-intensity activities such as walking can reduce one’s risk for clinical depression. So, what are the most common ...
Blue Monday originated from a publicity stunt, but seasonal affective disorder is a real affliction that affects millions of ...
Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...
Investigators found negative mental health conditions among women firefighters may reduce levels of key hormone associated with ovarian reserve.
Discover the difference between burnout vs depression, including causes, symptoms, and how both are treated, according to ...
Teens dealing with stress tend to struggle as they enter the labor force as young adults, which can affect their pay, according to a study.
Better book a session with your therapist — yet another painful consequence of your parents’ divorce has emerged.
President Trump called DST costly and inconvenient. Understanding its history, health impact, and remedies is important.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback